Toujeo 300 U/mL Solostar
Marketer
Sanofi India Ltd
Salt Composition
Insulin Glargine (300u/ml)
Overview Toujeo 300 U/mL Solostar
Insulin glargine 300 U/mL (SoloStar) is a prolonged-release insulin formulation indicated for managing type 1 and type 2 diabetes in adults and pediatric patients. It offers consistent, 24-hour glycemic control, mitigating diabetes-related complications. This insulin may be used as monotherapy or in conjunction with rapid-acting insulin or other antidiabetic agents. Administered subcutaneously, the prescribed dosage must be followed diligently for optimal efficacy. Discontinuation can lead to dangerously elevated blood glucose, potentially causing severe health issues. Successful diabetes management requires a holistic approach encompassing this medication, a balanced diet, regular physical activity, and weight management as directed by your physician. Hypoglycemia (low blood sugar) is a prevalent adverse effect; meticulous dose adherence, consistent meal timing, and regular blood glucose monitoring are crucial for prevention. Alcohol consumption should be moderated due to its hypoglycemic potential. Additional potential side effects include peripheral swelling, fat tissue changes at the injection site (lipodystrophy), hypersensitivity reactions, injection site reactions, pruritus (itching), skin rashes, and weight increase. Avoid use if hypoglycemic. Prior to initiating treatment, disclose any existing kidney, liver, or cardiac conditions to your doctor. Consult your physician regarding use during pregnancy or breastfeeding.
Uses of Toujeo 300 U/mL Solostar
High blood sugar
Major Benefits of Toujeo 300 U/mL Solostar:
Your healthcare provider will instruct you on the proper administration of this medication.
Common Side effects of Toujeo 300 U/mL Solostar:
- Hypoglycemia (low blood glucose level)
- Peripheral edema
- Lipodystrophy (skin thickening or pits at the injection site)
- Allergic reaction
- Injection site reactions (pain, swelling, redness)
- Itching
- Rash
- Weight gain
How to use Toujeo 300 U/mL Solostar:
Your healthcare provider will instruct you on the proper administration of this medication.
How Toujeo 300 U/mL Solostar works:
SoloStar Toujeo 300 U/mL, a prolonged-release insulin formulation, delivers stable blood glucose management throughout the day. Its mechanism mirrors the action of endogenous insulin, promoting glucose uptake into muscle and adipose tissue while concurrently inhibiting hepatic glucose output.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Toujeo 300 U/mL Solostar is not recommended due to safety concerns.
PregnancySAFE IF PRESCRIBED
The use of Toujeo 300 U/mL Solostar during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; yet, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Toujeo 300 U/mL Solostar while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Individuals with impaired kidney function should use Solostar insulin glargine 300 U/mL cautiously. Dosage modification of Solostar insulin glargine 300 U/mL may be necessary. Physician consultation is advised. Routine blood glucose monitoring is recommended to guide dosage alterations.
LiverCAUTION
Individuals with hepatic impairment should use Solostar 300 U/mL insulin glargine cautiously. Dosage modification of Solostar 300 U/mL insulin glargine may be necessary. Physician consultation is advised. Consistent blood glucose monitoring is recommended to guide dosage adjustments.
What if you forget to take Toujeo 300 U/mL Solostar :
Should you forget a Toujeo 300 U/mL Solostar injection, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Toujeo 300 U/mL Solostar
| Label | Value |
|---|---|
| Chemical Type | Insulin analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Long-acting insulin analogs |
3,018 People bought this recently